117
Participants
Start Date
June 23, 2017
Primary Completion Date
March 28, 2022
Study Completion Date
November 2, 2023
Trastuzumab
Given intravenously (into the vein; IV)
Tucatinib
Given orally
Cliniques Universitaires Saint Luc, Brussels
Universitair Ziekenhuis Antwerpen, Edegem
UZ Leuven campus Gasthuisberg, Leuven
Memorial Sloan Kettering Cancer Center, New York
Roswell Park Cancer Institute, Buffalo
Allegheny General Hospital, Pittsburgh
Lombardi Cancer Center / Georgetown University Medical Center, Washington D.C.
Instituto Europeo di Oncologia, Milan
Niguarda Ca' Granda Hospital, Milan
Center Georges Francois Leclerc, Dijon
Hospitalier Jean Minjoz, Besançon
Duke University Medical Center, Durham
Hospital General Universitario Gregorio Maranon, Madrid
Winship Cancer Institute / Emory University School of Medicine, Atlanta
Florida Cancer Specialists - North Region, St. Petersburg
Florida Cancer Specialists - South Region, Fort Myers
University of Alabama at Birmingham, Birmingham
Tennessee Oncology-Nashville/Sarah Cannon Research Institute, Nashville
Vanderbilt University Medical Center, Nashville
Case Western Reserve University / University Hospitals Cleveland Medical Center, Cleveland
Hospital Clinico Universitario de Valencia, Valencia
Indiana University Simon Cancer Center, Indianapolis
Karmanos Cancer Institute / Wayne State University, Detroit
University of Iowa Hospitals and Clinics, Iowa City
Aurora Research Institute Cancer Center, Milwaukee
Mayo Clinic Rochester, Rochester
Azienda Ospedaliero-Universitaria Pisana - Ospedale S. Chiara, Pisa
University of Kansas Cancer Center, Westwood
Centre Leon Berard - Centre regional de lutte contre le cancer Rhone-Alpes, Lyon
Hopital Saint-Antoine, Paris
Texas Oncology - Baylor Sammons Cancer Center, Dallas
Texas Oncology - Tyler, Tyler
Texas Oncology - San Antonio Medical Center, San Antonio
Texas Oncology - McAllen, McAllen
Joe Arrington Cancer Research and Treatment Center, Lubbock
Rocky Mountain Cancer Centers - Aurora, Aurora
Huntsman Cancer Institute/University of Utah, Salt Lake City
Mayo Clinic Arizona, Phoenix
Banner MD Anderson Cancer Center, Gilbert
Comprehensive Cancer Centers of Nevada, Las Vegas
Keck Medical Center / University of Southern California, Los Angeles
Cedars Sinai Medical Center / Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Pacific Shores Medical Group, Long Beach
Hôpital Franco-Britannique - Fondation Cognacq-Jay, Levallois-Perret
Stanford University School of Medicine, Palo Alto
Saint Joseph Heritage Medical Group, Santa Rosa
Northwest Cancer Specialists, P.C., Portland
Providence Regional Medical Center Everett, Everett
University of Chicago Medical Center, Chicago
Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston
Oregon Health and Science University, Portland
Texas Oncology - Beaumont, Beaumont
Seattle Cancer Care Alliance / University of Washington, Seattle
Hospital Universitario Vall d'Hebron, Barcelona
Institut Catala d'Oncologia - Hospital Duran i Reynals (ICO L'Hospitalet), L'Hospitalet de Llobregat
National Cancer Institute (NCI)
NIH
Academic and Community Cancer Research United
OTHER
Seagen Inc.
INDUSTRY